145 related articles for article (PubMed ID: 27717885)
1. Myxoid leiomyosarcoma of the uterus: a clinicopathological and immunohistochemical study of 10 cases.
Lu B; Shi H; Zhang X
Hum Pathol; 2017 Jan; 59():139-146. PubMed ID: 27717885
[TBL] [Abstract][Full Text] [Related]
2. Myxoid Leiomyosarcoma of the Uterus: A Clinicopathologic Analysis of 30 Cases and Review of the Literature With Reappraisal of Its Distinction From Other Uterine Myxoid Mesenchymal Neoplasms.
Parra-Herran C; Schoolmeester JK; Yuan L; Dal Cin P; Fletcher CD; Quade BJ; Nucci MR
Am J Surg Pathol; 2016 Mar; 40(3):285-301. PubMed ID: 26866354
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic value of progesterone receptor, p16, p53 and pHH3 expression in uterine atypical leiomyoma.
Liang Y; Zhang X; Chen X; Lü W
Int J Clin Exp Pathol; 2015; 8(6):7196-202. PubMed ID: 26261614
[TBL] [Abstract][Full Text] [Related]
4. Myxoid leiomyosarcoma of the uterus.
Burch DM; Tavassoli FA
Histopathology; 2011 Dec; 59(6):1144-55. PubMed ID: 22175894
[TBL] [Abstract][Full Text] [Related]
5. Myxoid Mesenchymal Tumors of the Uterus: An Update on Classification, Definitions, and Differential Diagnosis.
Busca A; Parra-Herran C
Adv Anat Pathol; 2017 Nov; 24(6):354-361. PubMed ID: 28787279
[TBL] [Abstract][Full Text] [Related]
6. Uterine leiomyosarcomas: tumor size, mitotic index, and biomarkers Ki67, and Bcl-2 identify two groups with different prognosis.
D'Angelo E; Espinosa I; Ali R; Gilks CB; Rijn Mv; Lee CH; Prat J
Gynecol Oncol; 2011 May; 121(2):328-33. PubMed ID: 21316747
[TBL] [Abstract][Full Text] [Related]
7. Uterine sarcoma Part I-Uterine leiomyosarcoma: The Topic Advisory Group systematic review.
Wen KC; Horng HC; Wang PH; Chen YJ; Yen MS; Ng HT;
Taiwan J Obstet Gynecol; 2016 Aug; 55(4):463-71. PubMed ID: 27590365
[TBL] [Abstract][Full Text] [Related]
8. Primary and secondary leiomyosarcoma of the oral and perioral region--clinicopathological and immunohistochemical analysis of a rare entity with a review of the literature.
Schütz A; Smeets R; Driemel O; Hakim SG; Kosmehl H; Hanken H; Kolk A
J Oral Maxillofac Surg; 2013 Jun; 71(6):1132-42. PubMed ID: 23434173
[TBL] [Abstract][Full Text] [Related]
9. Leiomyosarcoma of the uterus: A clinicopathologic, DNA flow cytometric, p53, and mdm-2 analysis of 49 cases.
Blom R; Guerrieri C; Stâl O; Malmström H; Simonsen E
Gynecol Oncol; 1998 Jan; 68(1):54-61. PubMed ID: 9454661
[TBL] [Abstract][Full Text] [Related]
10. An immunohistochemical analysis of stathmin 1 expression in uterine smooth muscle tumors: differential expression in leiomyosarcomas and leiomyomas.
Allen MM; Douds JJ; Liang SX; Desouki MM; Parkash V; Fadare O
Int J Clin Exp Pathol; 2015; 8(3):2795-801. PubMed ID: 26045786
[TBL] [Abstract][Full Text] [Related]
11. "Low-grade leiomyosarcoma" and late-recurring smooth muscle tumors of the uterus: a heterogenous collection of frequently misdiagnosed tumors associated with an overall favorable prognosis relative to conventional uterine leiomyosarcomas.
Veras E; Zivanovic O; Jacks L; Chiappetta D; Hensley M; Soslow R
Am J Surg Pathol; 2011 Nov; 35(11):1626-37. PubMed ID: 21921786
[TBL] [Abstract][Full Text] [Related]
12. Uterine leiomyosarcoma with myxoid stroma.
Pounder DJ; Iyer PV
Arch Pathol Lab Med; 1985 Aug; 109(8):762-4. PubMed ID: 3839378
[TBL] [Abstract][Full Text] [Related]
13. Metastatic pattern of uterine leiomyosarcoma: retrospective analysis of the predictors and outcome in 113 patients.
Tirumani SH; Deaver P; Shinagare AB; Tirumani H; Hornick JL; George S; Ramaiya NH
J Gynecol Oncol; 2014 Oct; 25(4):306-12. PubMed ID: 25142630
[TBL] [Abstract][Full Text] [Related]
14. Epithelioid leiomyosarcoma of the uterus with oncocytic change.
Nguyen GK; Russell L; Honoré L; Vriends R
Pathol Res Pract; 2001; 197(9):643-6. PubMed ID: 11569929
[TBL] [Abstract][Full Text] [Related]
15. Uterine myxoid leiomyosarcoma - a rare malignant tumor: the role of complex morphopathological assay. Review and case presentation.
Istrate-Ofiţeru AM; Zorilă GL; Ruican D; Petrescu AM; Berbecaru EIA; Roşu GC; Căpitănescu RG; Nagy RD; Cercelaru L; Edu A; Iliescu DG; Drăguşin RC
Rom J Morphol Embryol; 2021; 62(4):883-896. PubMed ID: 35673808
[TBL] [Abstract][Full Text] [Related]
16. Oncofetal protein IMP3: a useful diagnostic biomarker for leiomyosarcoma.
Cornejo K; Shi M; Jiang Z
Hum Pathol; 2012 Oct; 43(10):1567-72. PubMed ID: 22497850
[TBL] [Abstract][Full Text] [Related]
17. Abnormal p53 and p16 staining patterns distinguish uterine leiomyosarcoma from inflammatory myofibroblastic tumour.
Schaefer IM; Hornick JL; Sholl LM; Quade BJ; Nucci MR; Parra-Herran C
Histopathology; 2017 Jun; 70(7):1138-1146. PubMed ID: 28130839
[TBL] [Abstract][Full Text] [Related]
18. Atypical uterine leiomyoma: a case report and review of the literature.
Manxhuka-Kerliu S; Kerliu-Saliu I; Sahatciu-Meka V; Kerliu L; Shahini L
J Med Case Rep; 2016 Jan; 10():22. PubMed ID: 26801982
[TBL] [Abstract][Full Text] [Related]
19. Bcl-2 receptor expression in patients with uterine smooth muscle tumors: an immunohistochemical analysis comparing leiomyoma, uterine smooth muscle tumor of uncertain malignant potential, and leiomyosarcoma.
Bodner K; Bodner-Adler B; Kimberger O; Czerwenka K; Mayerhofer K
J Soc Gynecol Investig; 2004 Apr; 11(3):187-91. PubMed ID: 15051039
[TBL] [Abstract][Full Text] [Related]
20. Nestin: A biomarker of aggressive uterine cancers.
Hope ER; Mhawech-Fauceglia P; Pejovic T; Zahn CM; Wang G; Conrads TP; Larry Maxwell G; Hamilton CA; Darcy KM; Syed V
Gynecol Oncol; 2016 Mar; 140(3):503-11. PubMed ID: 26718725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
